122 related articles for article (PubMed ID: 36525755)
21. Impact of 21-Gene Expression Assay on Clinical Outcomes in Node-Negative ≤ T1b Breast Cancer.
Pomponio M; Keele L; Hilt E; Burkbauer L; Goldbach M; Nazarian S; Fox K; Tchou J
Ann Surg Oncol; 2020 May; 27(5):1671-1678. PubMed ID: 31686348
[TBL] [Abstract][Full Text] [Related]
22. Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
Lips EH; Mukhtar RA; Yau C; de Ronde JJ; Livasy C; Carey LA; Loo CE; Vrancken-Peeters MJ; Sonke GS; Berry DA; Van't Veer LJ; Esserman LJ; Wesseling J; Rodenhuis S; Shelley Hwang E;
Breast Cancer Res Treat; 2012 Nov; 136(1):35-43. PubMed ID: 22961065
[TBL] [Abstract][Full Text] [Related]
23. Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast.
Kizy S; Huang JL; Marmor S; Tuttle TM; Hui JYC
Breast Cancer Res Treat; 2017 Oct; 165(3):757-763. PubMed ID: 28647915
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.
Inwald EC; Koller M; Klinkhammer-Schalke M; Zeman F; Hofstädter F; Lindberg P; Gerstenhauer M; Schüler S; Treeck O; Ortmann O
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2229-40. PubMed ID: 26253629
[TBL] [Abstract][Full Text] [Related]
25. Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy.
Wong H; Lau S; Cheung P; Wong TT; Parker A; Yau T; Epstein RJ
BMC Cancer; 2014 Nov; 14():826. PubMed ID: 25385074
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience.
Okines A; Irfan T; Asare B; Mohammed K; Osin P; Nerurkar A; Smith IE; Parton M; Ring A; Johnston S; Turner NC
Breast Cancer Res Treat; 2022 Apr; 192(3):563-571. PubMed ID: 35119530
[TBL] [Abstract][Full Text] [Related]
27. Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis.
van de Water W; Fontein DB; van Nes JG; Bartlett JM; Hille ET; Putter H; Robson T; Liefers GJ; Roumen RM; Seynaeve C; Dirix LY; Paridaens R; Kranenbarg EM; Nortier JW; van de Velde CJ
Eur J Cancer; 2013 Jan; 49(2):297-304. PubMed ID: 22954666
[TBL] [Abstract][Full Text] [Related]
28. The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.
Tamirisa N; Williamson HV; Thomas SM; Westbrook KE; Greenup RA; Plichta JK; Rosenberger LH; Hyslop T; Hwang ES; Fayanju OM
J Surg Oncol; 2019 Aug; 120(2):132-141. PubMed ID: 31062375
[TBL] [Abstract][Full Text] [Related]
29. Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study.
Dalenc F; Lusque A; De La Motte Rouge T; Pistilli B; Brain E; Pasquier D; Debled M; Thery JC; Gonçalves A; Desmoulins I; Levy C; Uwer L; Ferrero JM; Eymard JC; Mouret-Reynier MA; Patsouris A; Frenel JS; Petit T; Chevrot M; Bachelot T; Guiu S
Eur J Cancer; 2022 Mar; 164():70-79. PubMed ID: 35176614
[TBL] [Abstract][Full Text] [Related]
30. The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable.
Chin-Lenn L; De Boer RH; Segelov E; Marx GM; Hughes TM; McCarthy NJ; White SC; Foo SS; Rutovitz JJ; Della-Fiorentina S; Jennens R; Antill YC; Tsoi D; Cronk MF; Lombard JM; Kiely BE; Chirgwin JH; Gorelik A; Mann GB
Asia Pac J Clin Oncol; 2018 Dec; 14(6):410-416. PubMed ID: 30270527
[TBL] [Abstract][Full Text] [Related]
31. Invasive Lobular Carcinoma Has Worse Outcome Compared with Invasive Ductal Carcinoma in Stage IV Breast Cancer with Bone-Only Metastasis.
Luo Y; Ma A; Huang S; Yu Y
Breast Care (Basel); 2022 Jun; 17(3):296-305. PubMed ID: 35949419
[TBL] [Abstract][Full Text] [Related]
32. Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.
Metzger Filho O; Giobbie-Hurder A; Mallon E; Gusterson B; Viale G; Winer EP; Thürlimann B; Gelber RD; Colleoni M; Ejlertsen B; Debled M; Price KN; Regan MM; Coates AS; Goldhirsch A
J Clin Oncol; 2015 Sep; 33(25):2772-9. PubMed ID: 26215945
[TBL] [Abstract][Full Text] [Related]
33. The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis.
Makower D; Qin J; Lin J; Xue X; Sparano JA
NPJ Breast Cancer; 2022 Jan; 8(1):4. PubMed ID: 35027533
[TBL] [Abstract][Full Text] [Related]
34. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
[TBL] [Abstract][Full Text] [Related]
35. The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer.
Jenkins JA; Marmor S; Hui JYC; Beckwith H; Blaes AH; Potter D; Tuttle TM
Breast Cancer Res Treat; 2022 Jan; 191(2):401-407. PubMed ID: 34716509
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant Therapy in Breast Cancer Patients With Microscopic Residual Disease.
Cao L; Shenk R; Stabellini N; Amin AL; Montero AJ; Towe CW
J Surg Res; 2023 May; 285():114-120. PubMed ID: 36657304
[TBL] [Abstract][Full Text] [Related]
37. Benefit of adjuvant chemotherapy in patients with lobular breast cancer: A systematic review of the literature and metanalysis.
Trapani D; Gandini S; Corti C; Crimini E; Bellerba F; Minchella I; Criscitiello C; Tarantino P; Curigliano G
Cancer Treat Rev; 2021 Jun; 97():102205. PubMed ID: 33878560
[TBL] [Abstract][Full Text] [Related]
38. How Does Invasive Breast Cancer Oncotype Dx Recurrence Score on Core Needle Biopsies Influence Neoadjuvant Treatment Decision? A Descriptive Study.
Nam G; Singh K; Lopresti ML; Ouseph MM; Wang LJ; Wang Y
Technol Cancer Res Treat; 2021; 20():15330338211035037. PubMed ID: 34696631
[TBL] [Abstract][Full Text] [Related]
39. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract][Full Text] [Related]
40. Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma.
Loibl S; Volz C; Mau C; Blohmer JU; Costa SD; Eidtmann H; Fasching PA; Gerber B; Hanusch C; Jackisch C; Kümmel S; Huober J; Denkert C; Hilfrich J; Konecny GE; Fett W; Stickeler E; Harbeck N; Mehta KM; Nekljudova V; von Minckwitz G; Untch M
Breast Cancer Res Treat; 2014 Feb; 144(1):153-62. PubMed ID: 24504379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
